Category: Forbes

FDA Vote On Future Covid-19 Vaccines Is A Call To Action To Boost Rates

The aggressive U.S. Covid-19 vaccine roll-out coupled with a disappointing public uptake is a call-to-action to understand why and to develop informed interventions.

Is A Broadly Protective And Long Lasting Hepatitis C Vaccine Possible?

Current understanding of the hepatitis C virus requires that a vaccine be both broadly protective and long lasting.

More People Got Diabetes During The Covid Pandemic—Here’s Why

Over 37 million Americans have diabetes, including over 280,000 adolescents under the age of 20.

BJC Healthcare Eyes $10 Billion Union With Saint Luke’s Health System: Is Consolidation Healthy Or A Case Of ‘Too Big To Fail,’ Too Big To Care?

Given the size and revenue of these institutions it raises the question of what consolidation can achieve that such an already large system can’t achieve on its own.

To Kill And Kill Again: How Cytotoxic T Cells Attack Target After Target

Research using high resolution, three dimensional imaging reveals new insights on how killer T cells swiftly kill target after target.

With CVS Health’s Exit, Walgreens Steps Up Clinical Research With Cancer Test Partner

Walgreens expanded its clinical trials and research business, partnering with Freenome to “increase diversity in research focused on the early detection of cancer.”

She DOES Survive: Grammy-Winner Gloria Gaynor Battles Self-Doubt & Surgeries With Spirituality & Self-Love

Disco legend Gloria Gaynor overcomes sexual abuse, divorce, financial struggles and major spinal surgery in new documentary film at Tribeca Festival.

InnovationRx: Scientists May Have Figured Out What’s Behind Long Covid

InnovationRx is your weekly digest of healthcare news. Sign up!

Taking ‘Smart Drugs’ Like Adderall Without ADHD Actually Decreases Productivity–Here’s How

Using ADHD drugs when you don’t have it may make you work more—but less successfully.

The Road To CRISPR Vision

Stem cell therapies have been making significant progress in restoring vision loss. Here we describe recent advances that use CRISPR to treat retinitis pigmentosa.